BTI
ONC

Blue Trust Inc’s BeOne Medicines Ltd ONC Stock Holding History

Blue Trust Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
805
-21
-3% -$6.19K ﹤0.01% 746
2026
Q1 		$245K Sell
826
-74
-8% -$24K ﹤0.01% 706
2025
Q4 		$273K Sell
900
-67
-7% -$21.9K ﹤0.01% 684
2025
Q3 		$329K Buy
967
+101
+12% +$30.7K ﹤0.01% 626
2025
Q2 		$210K Buy
866
+856
+8,560% +$210K ﹤0.01% 756
2025
Q1 		$2.72K Sell
10
-5
-33% -$1.17K ﹤0.01% 2188
2024
Q4 		$2.68K Sell
15
-108
-88% -$22.1K ﹤0.01% 2182
2024
Q3 		$17.5K Buy
123
+75
+156% +$13.5K ﹤0.01% 1995
2024
Q2 		$7.51K Buy
48
+34
+243% +$5.24K ﹤0.01% 2037
2024
Q1 		$2.19K Sell
14
-51
-78% -$8.21K ﹤0.01% 1808
2023
Q4 		$11K Buy
65
+33
+103% +$5.97K ﹤0.01% 1564
2023
Q3 		$6K Buy
32
+10
+45% +$1.98K ﹤0.01% 1613
2023
Q2 		$5K Sell
22
-147
-87% -$33.9K ﹤0.01% 1561
2023
Q1 		$37K Buy
169
+127
+302% +$30.5K ﹤0.01% 1154
2022
Q4 		$6K Buy
42
+41
+4,100% +$7.52K ﹤0.01% 1698
2022
Q3 		$0 Sell
1
-22
-96% -$3.78K ﹤0.01% 2364
2022
Q2 		$4K Buy
+23
New +$3.59K ﹤0.01% 1536

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Blue Trust Inc's ONC Position: Q2 2026 in Review

Blue Trust Inc reduced its BeOne Medicines Ltd (ONC) stake by 2.5% in Q2 2026, selling an estimated $6.19K and leaving 805 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Blue Trust Inc first reported a position in ONC in Q2 2022 and has held it in 17 quarters since. The position peaked at $329K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Blue Trust Inc held 805 shares of BeOne Medicines Ltd worth $229K as of Q2 2026.
  • Blue Trust Inc sold 21 BeOne Medicines Ltd shares in Q2 2026, an estimated $6.19K.
  • BeOne Medicines Ltd made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #746 holding.
  • Blue Trust Inc first reported a position in BeOne Medicines Ltd in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's BeOne Medicines Ltd position peaked at $329K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.